Skip to Main Content

View Public Comments for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease

Use the browser below to select the Comment Period for which you would like to view the comments for the selected document. You can use the alphabetical links above the results table to jump to comments submitted by a commenter whose last name starts with that letter. Select the ‘Expand All Comments’ link to view all the full comments, and click the ‘Collapse All Comments’ link to view only the abstract for all comments. Select the ‘More’ link in the Comment to view the full text of the specific comment in a new window.
The first (earliest) set of comments are displayed by default in the Public Comment Results section. To view additional Comment Periods, use the radio button options and select the "Submit" button.
An asterisk (*) indicates a required field.

      Select one period.


[27 Comments]
Page 1 of 2
FirstPrev12NextLast
First character of titleCommenterComment Information
A
Abraham, Brian Title: Sr. Policy Director
Organization: Medical Imaging & Technology Alliance
Date: 11/08/2012
Comment:

November 8, 2012

Dear Dr. Hutter, Ms. Burton, and Mr. Caplan:

The Medical Imaging & Technology Alliance (MITA) appreciates this opportunity to respond to the Centers for Medicare and Medicaid Services’ (CMS’) request for More opens in new window

B
Bhujwalla, Zaver Title: President
Organization: World Molecular Imaging Society
Date: 10/25/2012
Comment:

October 25, 2012

BY ELECTRONIC DELIVERY

Louis Jacques, M.D.
Coverage and Analysis Group, Director
Centers for Medicare & Medicaid Services
Department of Health and Human Services
2500 Security More opens in new window

B
Bocchino, Carmella Title: EVP, Clinical Affairs and Strategic Planning
Organization: America's Health Insurance Plans (AHIP)
Date: 11/08/2012
Comment:

November 8, 2012

Brijet Burton, MPP, MS, PA-C
Lead Analyst
Centers for Medicare and Medicaid Services
Mail Stop C1-09-06
7500 Security Boulevard
Baltimore, Maryland 21244-1850

Dear Ms. More opens in new window

B
Boeve, M.D, Bradley Title: Chair, Division of Behavioral Neurology
Organization: Mayo Clinic
Date: 11/07/2012
Comment:

November 7, 2012

Joseph Hutter, MD, MA
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244

Re: National Coverage Analysis (NCA) Tracking Sheet for Beta Amyloid More opens in new window

B
Brewer, James Title: Associate Professor, Radiology and Neurosciences
Organization: UC San Diego
Date: 10/24/2012
Comment:

Dear Dr. Hutter and Ms. Burton,

I am certainly in favor of providing physicians with more, rather than fewer, tools for arriving at earlier and more accurate diagnoses. This is particularly so when the existing diagnostic approach is More opens in new window

B
Bunning, Sue Title: Director, Health Policy & Regulatory Affairs
Organization: Society of Nuclear Medicine and Molecular Imaging
Date: 11/08/2012
Comment:

Louis Jacques, M.D.
Director, Coverage and Analysis Group
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244

RE: Comments regarding National Coverage Analysis More opens in new window

D
Devous, Michael Title: Professor of Radiology
Organization: University of Texas Southwestern Medical Center
Date: 11/08/2012
Comment:

The recent FDA approval of Amyvid for PET imaging of neuritic beta amyloid plaques in patients with cognitive alterations possibly caused by Alzheimer’s disease is a critically valuable advance in the diagnosis and management of patients with More opens in new window

D
Dinkelborg, Ludger Title: Managing Director
Organization: Piramal Imaging S.A.
Date: 11/08/2012
Comment:

November 7, 2012

Centers for Medicare and Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244-1850

RE: National Coverage Analysis (NCA) for Beta Amyloid Positron Emission Tomography in More opens in new window

D
Dougherty , MD, John Title: Medical Director - Neurologist
Organization: Cole Neuroscience Center at UT Medical Center - Knoxville
Date: 11/08/2012
Comment:
Title: Medical Director, Neurologist
Organization: Cole Neuroscience Center – University of Tennessee Medical Center
Date: 11/08/2012
Louis Jacques, M.D.
Coverage and Analysis & Medicaid Services
Department of More opens in new window
D
Duffy, Michael P. Title: Vice President and General Counsel
Organization: Lantheus Medical Imaging
Date: 11/08/2012
Comment:

November 8, 2012

Joseph Hutter, MD, MA
Lead Medical Officer
Centers for Medicare and Medicaid Services
Coverage Analysis Group
7500 Security Boulevard
Baltimore, MD 21244

Brijet Burton, MPP, More opens in new window

D
Dutt, Katikuti swara Title: doctor.
Organization: internal medicine.
Date: 10/09/2012
Comment:
Alzheimer's disease is becoming a very common disease.Early diagnosis is important.That can be done by PET scan to identify Beta-aamyloid deposition in the brain. Otherwise difficult to treat. Hence, Pet scan should be approved to identify More opens in new window
F
Frank, MD, PhD., Richard Title: Vice President, Global Clinical Strategy & Policy
Organization: GE Healthcare
Date: 11/08/2012
Comment:

LETTER E-MAILED TO CAGinquiries@cms.hhs.gov

November 7, 2012

Joseph Hutter, MD, MA
Lead Medical Officer
Brijet Burton, MPP, MS, PA-C and Stuart Kaplan, RN, MAS
Lead Analysts
Coverage and Analysis More opens in new window

H
Hall, Eric Date: 11/08/2012
Comment:

November 8, 2012

Louis Jacques, M.D.
Coverage and Analysis Group, Director
Centers for Medicare & Medicaid Services
Department of Health and Human Services
2500 Security Boulevard
Baltimore, MD More opens in new window

H
Hunter, Craig Title: Senior Research Scientist
Organization: Eli Lilly and Company
Date: 10/26/2012
Comment:

October 26, 2012

Patrick Conway, MD, MSc
Chief Medical Officer and Director, Office of Clinical Standards and Quality
Centers for Medicare and Medicaid Services
Mail Stop S3-02-01
7500 Security More opens in new window

M
McGlothlin, Anita Title: Analyst
Organization: American College of Radiology
Date: 11/08/2012
Comment:

November 8, 2012

Louis Jacques, M.D.
Director, Coverage and Analysis Group
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244

VIA ELECTRONIC More opens in new window

P
Pitts, Aaron Title: Sr Vice President, Strategy, Sales & Marketing
Organization: Cardinal Health Nuclear Pharmacy Services
Date: 11/08/2012
Comment:

Cardinal Health is pleased to respond to the Centers for Medicaid and Medicare Services (CMS) request for comments on the reconsideration request of Section 220.6 of the National Coverage Determinations (NCD) Manual, dealing with Positron More opens in new window

R
Reed, Jessi Date: 10/10/2012
Comment:
PET.CT is a crucial diagnosis/prognosis/treatment tool used in medical areas such as oncology. The benefits of the introduction of FDG,in PET.CT to the diagnostic radiology /oncology world has been astronomical!!! Why would our nations government More opens in new window
S
Saba, Philip Title: Co-Director of Neuroimaging
Organization: Wake Radiology Consultants, PA
Date: 10/29/2012
Comment:
In my opinion, this test is of great value for a specific clinical indication - that being the assessment of the patient with cognitive impairment of undetermined etiology. While a positive result has no great value (due to the 30% prevalance of More opens in new window
S
Salloway, Stephen Title: Professor of Neurology and Psychiatry
Organization: Warren Alpert Medical School Brown University
Date: 11/07/2012
Comment:

November 7, 2012

Patrick Conway, MD, MSc
Chief Medical Officer and Director, Office of Clinical Standards and Quality
Centers for Medicare and Medicaid Services
Mail Stop S3-02-01
7500 Security More opens in new window

S
Schaefer, Pamela Title: President
Organization: American Society of Neuroradiology
Date: 11/08/2012
Comment:

November 8, 2012

Brijet Burton, MPP, MS, PA-C
Stuart Caplan, RN, MAS
Joseph Hutter, MD, MA
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD More opens in new window

S
Schwartz, Ronald Title: Neurologist
Organization: Hattiesburg Clinic
Date: 11/01/2012
Comment:

As Director of our Memory Clinic and Neurological Research Center, I have had the opportunity to work with AV-45 (amyloid-imaging agent). I have found the modality especially useful in patients with uncertain diagnosis or early stages of More opens in new window

S
Szabo, Zsolt Date: 11/08/2012
Comment:
November 8, 2012
Joseph Hutter, MD, MA
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244

Re: National Coverage Analysis (NCA) Tracking Sheet for Beta Amyloid Positron More opens in new window

V
Vradenburg, George Title: Chairman
Organization: USAgainstAlzheimer's
Date: 11/07/2012
Comment:

USAgainstAlzheimer's, the national mobilization network committed to stopping Alzheimer's disease by 2020, is pleased that the Centers for Medicare & Medicaid Services (CMS) is reconsidering its coverage policies regarding the use of PET More opens in new window

W
Wahl, Richard Title: Professor and Director: Nuclear Medicine
Organization: Johns Hopkins University School of Medicine
Date: 11/08/2012
Comment:

November 8, 2012

Joseph Hutter, MD, MA
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244

Re: National Coverage Analysis (NCA) Tracking Sheet for Beta Amyloid Positron More opens in new window

W
Weiner, Michael Title: Professor of Radiology
Organization: University of California, San Francisco
Date: 11/08/2012
Comment:

I've been doing research on Alzheimer's disease for 25 years and [PHI Redacted] has Alzheimer's disease. I'm the Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative, which has extensively and successfully More opens in new window

Page 1 of 2
FirstPrev12NextLast
18